RX Insider Trading Activity and SEC Form 4 Filings
RX insider trading summary
No open-market insider purchases or sales of Ims Health Inc (RX) have been reported on SEC Form 4 in the past 12 months.
Latest RX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 2, 2009 | John R Walsh | SVP, Payer & Government | Sell | $128K (9,395 @ $13.58) |
| Aug 21, 2009 | McKay S Kevin | SVP, Customer Delivery & Devel | Sell | $336K (25,000 @ $13.45) |
| Jul 27, 2009 | Adel Al-Saleh | President, IMS EMEA | Sell | $72K (6,000 @ $11.99) |
| Aug 22, 2008 | John R Walsh | SVP, Strategy & Business Dev | Sell | $52K (2,294 @ $22.78) |
| Aug 22, 2008 | John R Walsh | SVP, Strategy & Business Dev | Sell | $33K (1,442 @ $22.79) |
| May 28, 2008 | H Eugene Lockhart | Director | Sell | $7K (300 @ $24.16) |
| May 28, 2008 | H Eugene Lockhart | Director | Sell | $7K (300 @ $24.10) |
| May 28, 2008 | H Eugene Lockhart | Director | Sell | $102K (4,200 @ $24.18) |
| May 28, 2008 | H Eugene Lockhart | Director | Sell | $12K (500 @ $24.17) |
| May 28, 2008 | H Eugene Lockhart | Director | Sell | $63K (2,600 @ $24.15) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.